BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8977193)

  • 21. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.
    Boyington JC; Motyka SA; Schuck P; Brooks AG; Sun PD
    Nature; 2000 Jun; 405(6786):537-43. PubMed ID: 10850706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral antibody binding of the MHC class II molecule: a biochemical influence on CD4 T cell differentiation in HIV infection?
    Powell PD; Demartini JC
    J Theor Biol; 2001 Mar; 209(2):155-60. PubMed ID: 11401457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The orientation of a T cell receptor to its MHC class II:peptide ligands.
    Hong SC; Sant'Angelo DB; Dittel BN; Medzhitov R; Yoon ST; Waterbury PG; Janeway CA
    J Immunol; 1997 Nov; 159(9):4395-402. PubMed ID: 9379037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin superfamily proteins: structure, mechanisms, and drug discovery.
    Huang Z; Li S; Korngold R
    Biopolymers; 1997; 43(5):367-82. PubMed ID: 9566118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of memory CD4 T cell adhesion by CD4-MHC class II interaction.
    Metz DP; Farber DL; Konig R; Bottomly K
    J Immunol; 1997 Sep; 159(6):2567-73. PubMed ID: 9300674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive allelic polymorphism in the CDR2-like region of the miniature swine CD4 molecule.
    Gustafsson K; Germana S; Sundt TM; Sachs DH; LeGuern C
    J Immunol; 1993 Aug; 151(3):1365-70. PubMed ID: 8335933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of the alpha 2 region of HLA-DR molecules involved in CD4 binding.
    Gaubin M; Houlgatte R; Dettin M; Scarinci C; Martin M; Guardiola J; Di Bello C; Piatier-Tonneau D
    Hum Immunol; 1999 Apr; 60(4):273-81. PubMed ID: 10363718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Several indirect methods for analysis of CD4 self-association and its function in stable CD4-MHC-II binding].
    Xiao H; Li S; Shen BF; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):239-43. PubMed ID: 16013482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model.
    Giblin PA; Leahy DJ; Mennone J; Kavathas PB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1716-20. PubMed ID: 8127870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 and CD8 may adopt a similar mode of binding to their MHC ligands.
    Brinkworth RI
    Protein Eng; 1992 Mar; 5(2):151-5. PubMed ID: 1594569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding.
    Moebius U; Pallai P; Harrison SC; Reinherz EL
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8259-63. PubMed ID: 8367491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell receptors as drugs. Ligand binding domains of receptors as drugs: a potential new class of therapeutic agents.
    Yarbrough GG; Taylor DP
    J R Coll Physicians Lond; 1991 Oct; 25(4):309-11. PubMed ID: 1960687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7.
    Van Ryk D; Vimonpatranon S; Hiatt J; Ganesan S; Chen N; McMurry J; Garba S; Min S; Goes LR; Girard A; Yolitz J; Licavoli I; Wei D; Huang D; Soares MA; Martinelli E; Cicala C; Arthos J
    PLoS Pathog; 2023 Dec; 19(12):e1011860. PubMed ID: 38064524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a CD4 gene haplotype on the immune response in minipigs.
    Blanc F; Créchet F; Bruneau N; Piton G; Leplat JJ; Andréoletti F; Egidy G; Vincent-Naulleau S; Bourneuf E
    Immunogenetics; 2018 Apr; 70(4):209-222. PubMed ID: 29052750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome complexity in the coelacanth is reflected in its adaptive immune system.
    Saha NR; Ota T; Litman GW; Hansen J; Parra Z; Hsu E; Buonocore F; Canapa A; Cheng JF; Amemiya CT
    J Exp Zool B Mol Dev Evol; 2014 Sep; 322(6):438-63. PubMed ID: 24464682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning, expression, and characterization of fugu CD4, the first ectothermic animal CD4.
    Suetake H; Araki K; Suzuki Y
    Immunogenetics; 2004 Aug; 56(5):368-74. PubMed ID: 15322779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the contact sites on the CD4 molecule with class II MHC molecule: co-ligand versus co-receptor function.
    Huang B; Yachou A; Fleury S; Hendrickson WA; Sekaly RP
    J Immunol; 1997 Jan; 158(1):216-25. PubMed ID: 8977193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
    J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.